$0.28 EPS Expected for Exponent, Inc. (EXPO)

September 15, 2018 - By Catherine Diaz

Exponent, Inc. (NASDAQ:EXPO) LogoInvestors sentiment increased to 10.29 in 2018 Q2. Its up 8.98, from 1.31 in 2018Q1. It increased, as 10 investors sold Exponent, Inc. shares while 7 reduced holdings. 37 funds opened positions while 138 raised stakes. 91.47 million shares or 309.92% more from 22.31 million shares in 2018Q1 were reported.
Tower Rech Capital (Trc) holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 80 shares. Eulav Asset, a New York-based fund reported 75,500 shares. Fmr Limited Liability reported 999,918 shares. Morgan Stanley reported 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Cubist Systematic Strategies Lc stated it has 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Moreover, Advisory Ser Net Ltd Company has 0% invested in Exponent, Inc. (NASDAQ:EXPO) for 268 shares. Jpmorgan Chase And stated it has 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Suntrust Banks holds 0.03% in Exponent, Inc. (NASDAQ:EXPO) or 98,588 shares. Bessemer Group Incorporated holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 632 shares. Signaturefd Limited Liability Company has invested 0% in Exponent, Inc. (NASDAQ:EXPO). Geode Mgmt Limited Liability Com reported 0.01% in Exponent, Inc. (NASDAQ:EXPO). Employees Retirement Association Of Colorado reported 541,232 shares stake. 649,604 are held by Df Dent. Chicago Equity Ltd Liability Company stated it has 20,280 shares or 0.03% of all its holdings. Alps Advisors Inc holds 0% in Exponent, Inc. (NASDAQ:EXPO) or 6,716 shares.

Since May 7, 2018, it had 0 buys, and 6 sales for $3.78 million activity. The insider Pye John sold 3,600 shares worth $322,154. Zumwalt Debra had sold 500 shares worth $48,004 on Friday, May 25. 2,639 Exponent, Inc. (NASDAQ:EXPO) shares with value of $248,161 were sold by Kytomaa Harri. Shares for $2.57 million were sold by SCHLENKER RICHARD L JR.

Analysts expect Exponent, Inc. (NASDAQ:EXPO) to report $0.28 EPS on October, 17.They anticipate $0.01 EPS change or 3.70 % from last quarter’s $0.27 EPS. EXPO’s profit would be $14.57M giving it 48.66 P/E if the $0.28 EPS is correct. After having $0.34 EPS previously, Exponent, Inc.’s analysts see -17.65 % EPS growth. The stock increased 1.40% or $0.75 during the last trading session, reaching $54.5. About 190,983 shares traded or 1.45% up from the average. Exponent, Inc. (NASDAQ:EXPO) has risen 51.61% since September 16, 2017 and is uptrending. It has outperformed by 35.99% the S&P500.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting firm worldwide. The company has market cap of $2.84 billion. The Company’s services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. It has a 58.86 P/E ratio. The firm operates in two divisions, Engineering and Other Scientific, and Environmental and Health.

Exponent, Inc. (NASDAQ:EXPO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.